ACRF provides grants for scientific equipment and other technologies as well as the establishment of capital works and facilities and national enterprises in support of all aspects of cancer research.
ACRF is a ‘seed’ funding body and is therefore interested in applications for larger scale research projects with value over and above the amount sought directly from ACRF. We expect applicants to leverage ACRF grants to secure any ‘gap’ funding and also to feature multi-disciplinary teams, collaborations and evidence of the translational impacts at a clinical level (with patients).
All applications are considered and assessed by our Medical Research Advisory Committee, a group of highly distinguished research scientists who are appointed by ACRF’s Board of Trustees.
The procedures of the Committee are similar to those employed by the National Health and Medical Research Council and include the assessment of applications by referees and independent expert assessors, as well as site visits and interviews of selected short-listed applicants.
The Committee’s recommendations for funding are reviewed and finalised by the ACRF Board of Trustees.
Due to the extraordinary situation being experienced in 2020 due to COVID-19 and in response to requests from prospective applicants the ACRF Board has agreed to extend this year’s Grant round closing to Friday 29 May 2020.
Please refer to the 2020 Grant Guidelines and 2020 Format of Application for further information.
ACRF is a private charity that provides major capital grants (between $1 Million to $10 Million) for infrastructure, equipment and technology for cancer research at Australian institutes, hospitals and universities. Grants are available for research into all types of cancer with a focus on detection, prevention and/or treatment.
In the past 36 years, ACRF has awarded $159.8 million in 75 research grants to 42 Australian cancer research institutes. These grants have enabled vital cancer research and have led to significant beneficial advances in the understanding of cancer and improving the treatments available to patients.
ACRF promotes collaboration amongst researchers and clinicians and encourages novel and innovative cancer research projects. All applications are competitively reviewed by the ACRF Medical Research Advisory Committee who recommend the best projects to the ACRF Board of Trustees for funding.
If you have any questions regarding ACRF grants process, please contact Cheryl Riddington on 1300 884 988 or firstname.lastname@example.org
People with pale coloured melanomas are more likely to have a gene mutation associated with albinism, University of Queensland researc...
An innovative technique to improve cancer treatments using tumour biopsies less than 30 minutes after they’re taken has been developed...